This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics in Point of Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics in Point of Care. This report contains market size and forecasts of Molecular Diagnostics in Point of Care in global, including the following market information:
Global Molecular Diagnostics in Point of Care Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Molecular Diagnostics in Point of Care market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polymerase Chain Reaction Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnostics in Point of Care include Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioM?rieux and Bio-Rad Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnostics in Point of Care companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostics in Point of Care Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Molecular Diagnostics in Point of Care Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Global Molecular Diagnostics in Point of Care Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Molecular Diagnostics in Point of Care Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Independent Clinical Laboratories
Global Molecular Diagnostics in Point of Care Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Molecular Diagnostics in Point of Care Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnostics in Point of Care revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Molecular Diagnostics in Point of Care revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton, Dickinson and Company
Binx Health
Biocartis
bioM?rieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnostics in Point of Care, market overview.
Chapter 2: Global Molecular Diagnostics in Point of Care market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnostics in Point of Care company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnostics in Point of Care in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Point of Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Point of Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Point of Care Overall Market Size
2.1 Global Molecular Diagnostics in Point of Care Market Size: 2022 VS 2029
2.2 Global Molecular Diagnostics in Point of Care Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Point of Care Players in Global Market
3.2 Top Global Molecular Diagnostics in Point of Care Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Point of Care Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Point of Care Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnostics in Point of Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Point of Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnostics in Point of Care Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction
4.1.3 In Situ Hybridization
4.1.4 Gene Chips
4.1.5 Next Generation Sequencing
4.2 By Type - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2024-2029
4.2.3 By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2029
5.1.2 Hospitals and Clinics
5.1.3 Independent Clinical Laboratories
5.2 By Application - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2024-2029
5.2.3 By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2029
6.2 By Region - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2024-2029
6.2.3 By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.3.2 US Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.3.3 Canada Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.3.4 Mexico Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.4.2 Germany Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.3 France Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.4 U.K. Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.5 Italy Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.6 Russia Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.7 Nordic Countries Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.8 Benelux Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.5.2 China Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.3 Japan Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.4 South Korea Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.5 Southeast Asia Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.6 India Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.6.2 Brazil Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.6.3 Argentina Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.7.2 Turkey Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7.3 Israel Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7.4 Saudi Arabia Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7.5 UAE Molecular Diagnostics in Point of Care Market Size, 2018-2029
7 Molecular Diagnostics in Point of Care Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Point of Care Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Company Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.2.4 Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.2.5 Accelerate Diagnostics Key News & Latest Developments
7.3 Ador Diagnostics
7.3.1 Ador Diagnostics Company Summary
7.3.2 Ador Diagnostics Business Overview
7.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.3.4 Ador Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.3.5 Ador Diagnostics Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Major Product Offerings
7.4.4 Beckman Coulter Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Company Summary
7.5.2 Becton, Dickinson and Company Business Overview
7.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Major Product Offerings
7.5.4 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.5.5 Becton, Dickinson and Company Key News & Latest Developments
7.6 Binx Health
7.6.1 Binx Health Company Summary
7.6.2 Binx Health Business Overview
7.6.3 Binx Health Molecular Diagnostics in Point of Care Major Product Offerings
7.6.4 Binx Health Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.6.5 Binx Health Key News & Latest Developments
7.7 Biocartis
7.7.1 Biocartis Company Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Molecular Diagnostics in Point of Care Major Product Offerings
7.7.4 Biocartis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.7.5 Biocartis Key News & Latest Developments
7.8 bioM?rieux
7.8.1 bioM?rieux Company Summary
7.8.2 bioM?rieux Business Overview
7.8.3 bioM?rieux Molecular Diagnostics in Point of Care Major Product Offerings
7.8.4 bioM?rieux Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.8.5 bioM?rieux Key News & Latest Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Company Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Major Product Offerings
7.9.4 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News & Latest Developments
7.10 Bosch Healthcare Solutions
7.10.1 Bosch Healthcare Solutions Company Summary
7.10.2 Bosch Healthcare Solutions Business Overview
7.10.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Major Product Offerings
7.10.4 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.10.5 Bosch Healthcare Solutions Key News & Latest Developments
7.11 Curetis
7.11.1 Curetis Company Summary
7.11.2 Curetis Business Overview
7.11.3 Curetis Molecular Diagnostics in Point of Care Major Product Offerings
7.11.4 Curetis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.11.5 Curetis Key News & Latest Developments
7.12 Eurofins Scientific
7.12.1 Eurofins Scientific Company Summary
7.12.2 Eurofins Scientific Business Overview
7.12.3 Eurofins Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.12.4 Eurofins Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.12.5 Eurofins Scientific Key News & Latest Developments
7.13 Genetic Signatures
7.13.1 Genetic Signatures Company Summary
7.13.2 Genetic Signatures Business Overview
7.13.3 Genetic Signatures Molecular Diagnostics in Point of Care Major Product Offerings
7.13.4 Genetic Signatures Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.13.5 Genetic Signatures Key News & Latest Developments
7.14 Grifols
7.14.1 Grifols Company Summary
7.14.2 Grifols Business Overview
7.14.3 Grifols Molecular Diagnostics in Point of Care Major Product Offerings
7.14.4 Grifols Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.14.5 Grifols Key News & Latest Developments
7.15 Hibergene Diagnostics
7.15.1 Hibergene Diagnostics Company Summary
7.15.2 Hibergene Diagnostics Business Overview
7.15.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.15.4 Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.15.5 Hibergene Diagnostics Key News & Latest Developments
7.16 Lumos Diagnostics
7.16.1 Lumos Diagnostics Company Summary
7.16.2 Lumos Diagnostics Business Overview
7.16.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.16.4 Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.16.5 Lumos Diagnostics Key News & Latest Developments
7.17 Roche
7.17.1 Roche Company Summary
7.17.2 Roche Business Overview
7.17.3 Roche Molecular Diagnostics in Point of Care Major Product Offerings
7.17.4 Roche Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.17.5 Roche Key News & Latest Developments
7.18 Siemens
7.18.1 Siemens Company Summary
7.18.2 Siemens Business Overview
7.18.3 Siemens Molecular Diagnostics in Point of Care Major Product Offerings
7.18.4 Siemens Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.18.5 Siemens Key News & Latest Developments
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Company Summary
7.19.2 Thermo Fisher Scientific Business Overview
7.19.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.19.4 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.19.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnostics in Point of Care Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnostics in Point of Care Market Drivers in Global Market
Table 3. Molecular Diagnostics in Point of Care Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnostics in Point of Care in Global Market
Table 5. Top Molecular Diagnostics in Point of Care Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Diagnostics in Point of Care Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Diagnostics in Point of Care Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Diagnostics in Point of Care Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics in Point of Care Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Molecular Diagnostics in Point of Care Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Diagnostics in Point of Care Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Company Summary
Table 31. Abbott Molecular Diagnostics in Point of Care Product Offerings
Table 32. Abbott Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Accelerate Diagnostics Company Summary
Table 35. Accelerate Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 36. Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 37. Accelerate Diagnostics Key News & Latest Developments
Table 38. Ador Diagnostics Company Summary
Table 39. Ador Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 40. Ador Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 41. Ador Diagnostics Key News & Latest Developments
Table 42. Beckman Coulter Company Summary
Table 43. Beckman Coulter Molecular Diagnostics in Point of Care Product Offerings
Table 44. Beckman Coulter Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 45. Beckman Coulter Key News & Latest Developments
Table 46. Becton, Dickinson and Company Company Summary
Table 47. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Product Offerings
Table 48. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 49. Becton, Dickinson and Company Key News & Latest Developments
Table 50. Binx Health Company Summary
Table 51. Binx Health Molecular Diagnostics in Point of Care Product Offerings
Table 52. Binx Health Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 53. Binx Health Key News & Latest Developments
Table 54. Biocartis Company Summary
Table 55. Biocartis Molecular Diagnostics in Point of Care Product Offerings
Table 56. Biocartis Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 57. Biocartis Key News & Latest Developments
Table 58. bioM?rieux Company Summary
Table 59. bioM?rieux Molecular Diagnostics in Point of Care Product Offerings
Table 60. bioM?rieux Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 61. bioM?rieux Key News & Latest Developments
Table 62. Bio-Rad Laboratories Company Summary
Table 63. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product Offerings
Table 64. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 65. Bio-Rad Laboratories Key News & Latest Developments
Table 66. Bosch Healthcare Solutions Company Summary
Table 67. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product Offerings
Table 68. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 69. Bosch Healthcare Solutions Key News & Latest Developments
Table 70. Curetis Company Summary
Table 71. Curetis Molecular Diagnostics in Point of Care Product Offerings
Table 72. Curetis Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 73. Curetis Key News & Latest Developments
Table 74. Eurofins Scientific Company Summary
Table 75. Eurofins Scientific Molecular Diagnostics in Point of Care Product Offerings
Table 76. Eurofins Scientific Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 77. Eurofins Scientific Key News & Latest Developments
Table 78. Genetic Signatures Company Summary
Table 79. Genetic Signatures Molecular Diagnostics in Point of Care Product Offerings
Table 80. Genetic Signatures Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 81. Genetic Signatures Key News & Latest Developments
Table 82. Grifols Company Summary
Table 83. Grifols Molecular Diagnostics in Point of Care Product Offerings
Table 84. Grifols Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 85. Grifols Key News & Latest Developments
Table 86. Hibergene Diagnostics Company Summary
Table 87. Hibergene Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 88. Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 89. Hibergene Diagnostics Key News & Latest Developments
Table 90. Lumos Diagnostics Company Summary
Table 91. Lumos Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 92. Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 93. Lumos Diagnostics Key News & Latest Developments
Table 94. Roche Company Summary
Table 95. Roche Molecular Diagnostics in Point of Care Product Offerings
Table 96. Roche Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 97. Roche Key News & Latest Developments
Table 98. Siemens Company Summary
Table 99. Siemens Molecular Diagnostics in Point of Care Product Offerings
Table 100. Siemens Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 101. Siemens Key News & Latest Developments
Table 102. Thermo Fisher Scientific Company Summary
Table 103. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Product Offerings
Table 104. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2018-2023)
Table 105. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Molecular Diagnostics in Point of Care Segment by Type in 2022
Figure 2. Molecular Diagnostics in Point of Care Segment by Application in 2022
Figure 3. Global Molecular Diagnostics in Point of Care Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnostics in Point of Care Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Molecular Diagnostics in Point of Care Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnostics in Point of Care Revenue in 2022
Figure 8. By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 9. By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 10. By Type - Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 12. By Application - Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 14. By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 15. By Country - North America Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 16. US Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 20. Germany Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 21. France Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 28. China Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 32. India Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 34. Brazil Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
Figure 37. Turkey Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ador Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Beckman Coulter Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Binx Health Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biocartis Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. bioM?rieux Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Curetis Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Eurofins Scientific Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Genetic Signatures Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Grifols Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Roche Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Siemens Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
